|
105 General support
claimed for Scottish academic body General
support exists for the creation of a body to provide academic leadership
for pharmacy in Scotland, although few details have been decided, according
to Graham Coombs, head of the Strathclyde Institute of Pharmacy and Biomedical
Sciences, and Terry Healey, head of the school of pharmacy at the Robert
Gordon University, who issued a statement this week
PJ 2008;280:105
Full Text
105 Society can become a members’ body again Once divested of its regulatory function, the Royal Pharmaceutical Society will become a members’ organisation once again and should continue, with expanded professional activities, as the professional body for pharmacy, according to the Joint Pharmaceutical Analysis Group
PJ 2008;280:105
Full Text
105 CCA and AIMp to tie the knot Moves that could lead to a merger of the Company Chemists’ Association and the Association of Independent Multiple Pharmacies (AIMp) have begun
PJ 2008;280:105
Full Text
106 Responsible pharmacist
plans not viable in hospital Responsible pharmacist
proposals are largely unworkable in registered hospital pharmacies and could
have a major destabilising effect on hospital pharmacy practice, according to
the Guild of Healthcare Pharmacists
PJ 2008;280:106
Full Text
106 PDA critical of Government consultation
on responsible pharmacist Fresh thought is needed on the relationship between company superintendent pharmacists and the proposed responsible pharmacists who are to be present in each community pharmacy. That is the core of the Pharmacists’ Defence Association response to the Government’s responsible pharmacist consultation
PJ 2008;280:106
Full Text
106 Government says that Health and Social Care
Bill could not allow Society to be stripped bare Reassurance
over words in the Health and Social Care Bill that were thought to threaten the
leadership role of the Royal Pharmaceutical Society, or whatever body supersedes
it, has been given by health minister Ben Bradshaw
PJ 2008;280:106
Full Text
107 Consultant pharmacists’ expertise should not be restricted to hospital patients, Society tells Darzi The
expertise of NHS consultant pharmacists should be available to all patients with
complex conditions whether or not they are admitted to hospital, the Royal Pharmaceutical
Society suggests in its submission to the NHS Next Stage Review for England
PJ 2008;280:107
Full Text
107 Guild proposes community pharmacy support
network Pharmacists with a special interest, and consultant pharmacists working across primary and secondary care, should form the basis of a clinical support network for community pharmacy, the Guild of Healthcare Pharmacists proposes in its response to Lord Darzi of Denham’s review of the NHS in England
PJ 2008;280:107
Full Text
107 Barriers to pharmacy lie within primary
care Barriers to the development of pharmacy services and the expansion of the profession’s clinical role in the community lie within primary care rather than in pharmacy policy, according to the Company Chemists’ Association
PJ 2008;280:107
Full Text
108 Complex relationship between
beliefs, ethics and knowledge leads to variability in EHC supply Pharmacists’ religious beliefs do not always influence their willingness to sell emergency hormonal contraception (EHC). However, most pharmacists have difficulty discussing ethical issues relating to EHC sales
PJ 2008;280:108
Full Text
108 The Lancet calls for OTC oral contraception A
further call has been made for oral contraceptives to become available over the
counter, following publication of a meta-analysis
PJ 2008;280:108
Full Text
108 Campaign to promote medicines use reviews
launched A campaign to promote medicines use reviews
has been launched by the Pharmaceutical Services Negotiating Committee
PJ 2008;280:108
Full Text
108 CD guidance for England Guidance
on recording supplies of Controlled Drugs in England has been published by the
Department of Health
PJ 2008;280:108
Full Text
108 NHS counter fraud An
updated counter fraud strategy for NHS Scotland was issued by the Scottish Government
this week
PJ 2008;280:108
Full Text
108 NHS Scotland waste New
guidance on dealing with waste in NHS Scotland has been published by Health Facilities
Scotland
PJ 2008;280:108
Full Text
108 Alliance Boots reaches China Alliance
Boots has moved into the Chinese pharmaceutical wholesale market by forming a
50:50 joint venture with a Chinese state-owned wholesaler Guangzhou Pharmaceutical
Company
PJ 2008;280:108
Full Text
109 Minor ailments cost NHS £2bn/yr Treating minor ailments accounts for a fifth of GPs’ workload and costs the NHS around £2bn a year, a study of data from 500,000 patients suggests. The research — commissioned by the Proprietary Association of Great Britain — also reveals that, in the UK, around 51 million consultations a year are solely for minor ailments
PJ 2008;280:109
Full Text
109 Extra funding for obesity services announced Extra funding to support the commissioning of more weight management services will be provided over the next three years, a new Government strategy aimed at reversing the rise in obesity in England says
PJ 2008;280:109
Full Text
109 Programme could explore earlier access to
medicines Discussion on enabling better access
to some medicines before their launch in the UK has taken place, facilitated
by the Ministerial Industry Strategy Group
PJ 2008;280:109
Full Text
109 Benefits of HPV vaccine continue to outweigh
risks Benefits of the human papillomavirus vaccine
Gardasil continue to outweigh its risks, says the European Medicines Agency (EMEA)
following several reports of sudden and unexpected deaths among young women who
had received the vaccine
PJ 2008;280:109
Full Text
109 Climate change guide launched Public
health implications of climate change in the UK are severe and cannot be ignored,
warns a guide published by the UK Faculty of Public Health last week
PJ 2008;280:109
Full Text
109 Energy efficiency body for NHS A
new body to monitor and encourage energy efficient practices throughout the NHS
in England is being established by the Government
PJ 2008;280:109
Full Text
109 Reduce your carbon footprint Health
professionals have an obligation to play a role in mitigating the effects of
climate change on health but they must first measure and reduce their own carbon
footprint so that they have the moral right to act as advocates, according to
Robin Stott, chairman of the Climate and Health Council
PJ 2008;280:109
Full Text
109 Medicinal plants face extinction Hundreds
of medicinal plant species are threatened with extinction because of habitat
loss, over-population, increasing urbanisation, destructive harvesting and agricultural
expansion, according to a report from Botanic Gardens Conservation International
PJ 2008;280:109
Full Text
110 Pharmacy academics shortage
needs to be tackled Action needs to be taken to
tackle the shortage of pharmacy-trained academics, Hemant Patel, President of
the Royal Pharmaceutical Society, said at a Society science dinner held in London
earlier this week
PJ 2008;280:110
Full Text
110 New topical antibiotic retapamulin launched Certain skin infections could by tackled with a new topical antibiotic — retapamulin — launched by GlaxoSmithKline last week
PJ 2008;280:110
Full Text
110 Tamiflu resistance identified Resistance
to oseltamivir has been discovered in some 13 per cent of influenza A (H1N1)
viruses in Europe, according to the Health Protection Agency this week
PJ 2008;280:110
Full Text
110 Novel sarcoma drug launched Patients with advanced soft tissue sarcoma whose standard therapy has failed could be eligible to receive a new orphan drug — trabectedin (Yondelis) — now available from biopharmaceutical company PharmaMar
PJ 2008;280:110
Full Text
110 Case handling consultation Consultation on the types of cases suitable for non-referral to the Royal Pharmaceutical Society’s Investigating Committee has been launched by the Society following a review of case handling
PJ 2008;280:110
Full Text
110 Rosiglitazone warning A warning that rosiglitazone is not recommended for patients with ischaemic heart disease or peripheral arterial disease should be included in the drug’s product information, the European Medicines Agency has announced
PJ 2008;280:110
Full Text |
The
Pharmaceutical Journal